Neural-immune Interactions in Cognitive Impairment Following Cancer Therapy or COVID
The event has not started yet...
Thursday, October 6, 2022, 12:00:00 PM, 1 hour.
| Description: | COVID-19 Scientific Interest Group
Michelle Monje is a leading neuroscientist and neuro-oncologist who is advancing our understanding of postnatal brain development and translating her findings into promising therapies for pediatric brain tumors. She has made seminal contributions to elucidating the phenomena of "chemobrain," a debilitating side effect of chemotherapy which include symptoms such as memory lapses, slowed thinking, and mental fog. Her COVID-themed seminar will be focused on her recent studies into the similarities between the chemobrain phenomena and the short- and long-term neurological effects of COVID. See https://med.stanford.edu/profiles/michelle-monje-deisseroth for more details about her research. For more information go to https://www.niaid.nih.gov/research/covid-19-sig |
| Stream: | |
| Author: | Michelle Leigh Monje-Deisseroth, M.D., Ph.D., Stanford University |
| Runtime: | 1 hour |
| Event ID: | 46143 |